Sensus Healthcare(US:SRTS) Globenewswire·2025-10-09 16:58Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Sensus Healthcare, Inc. for possible violations of federal securities laws and unlawful business practices [1][2]. Investigation Details - The investigation is focused on whether Sensus has engaged in any unlawful activities that may have affected its stockholders [1][2]. Financial Performance - On August 7, 2025, Sensus reported a second quarter GAAP earnings-per-share of -$0.06, missing estimates by $0.09 - Revenue for the same period was $7.3 million, reflecting a year-over-year decline of 20.7% and missing estimates by $2 million - The revenue decline was attributed to a lower number of units sold to a large customer, although there was some growth in recurring revenue from Fair Deal Agreements [6]. Stock Price Reaction - Following the financial results announcement, Sensus's stock price dropped by $1.89 per share, or 35.32%, closing at $3.46 per share on August 8, 2025 [6]. Next Steps for Investors - Investors who purchased Sensus shares and suffered losses are encouraged to contact Bragar Eagel & Squire for more information regarding their legal rights and potential claims [3]. About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in various types of litigation across the United States [4].